Stock Track | Neogen Soars Despite Q1 Earnings Miss on Strong Revenue Growth

Stock Track10-15

Shares of Neogen Corp (NEOG) surged by 5.06% on Monday despite the company reporting disappointing first-quarter fiscal 2025 earnings that missed analysts' estimates. The stock's rally was driven by stronger-than-expected revenue growth and positive signals from certain key product segments.

While Neogen reported adjusted earnings per share of 7 cents, down 36.4% year-over-year and missing the Zacks Consensus Estimate by 30%, the company's revenues of $217 million surpassed expectations by 0.4%. The Food Safety segment, which accounts for a significant portion of Neogen's business, saw core revenue growth of 1.1%, led by strong performance in biosecurity and indicator testing, as well as the Petrifilm product line.

Despite challenges in the Animal Safety segment and margin pressures due to higher costs, investors appear to have focused on the positive revenue growth and the company's ability to navigate headwinds like foreign currency fluctuations. The market's reaction suggests optimism about Neogen's long-term growth prospects, particularly in its core Food Safety business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment